Researchers are reporting two promising approaches to counteract malaria's growing drug resistance. Switzerland-based Novartis has released results for a new experimental drug called GanLum.

Global vaccine alliance Gavi and its partner Unicef will pay 25% less for a new malaria vaccine made by the Serum Institute ...

A single dose of a four-drug combination therapy for uncomplicated malaria was just as effective as the multi-day standard of ...

Edson Mwebesa, Fellow at the Wits-based Sub-Saharan Africa Advanced Consortium for Biostatistics (SSACAB), knows children who ...

In the 1960s drug-resistant strains of malaria emerged, making the disease even deadlier than before. Then, pharmaceutical scientist Tu Youyou discovered a promising new remedy buried within the pages ...

One of the world’s biggest funders of the fight against HIV, tuberculosis and malaria faces reduced funding for life-saving ...

Gavi and UNICEF's new agreement aims to make malaria vaccines more affordable, saving $90 million and benefiting millions of ...

For the past quarter-century, the gold standard malaria treatment has been artemisinin combination therapies (ACTs). Yet ...

The first new malaria treatment in decades holds promise against rising drug resistance after Swiss drugmaker Novartis ...

With victims numbering in the millions, malaria is an infectious disease caused by the bite of a mosquito carrying the ...

Ines’ research takes a multidisciplinary approach to understand the spread, evolution, and molecular interaction of the ...

A fungal infection solution could help eliminate up to 86% of malaria-carrying mosquitoes, offering a powerful new tool in ...